Login
Open Demat Account
Open Demat A/C
Offerings
+
Research
Markets+
Talking Finance+
Support+
Media+
Partner Us+
Trade LoginReports LoginIFD Partner Login
Demo
Close Language Tab
Locate us
Languages
  • Home
  • Company Information
  • Laurus Labs Ltd
L
Laurus Labs Ltd Pharmaceuticals
₹ 881.45 -28.40 (-3.12%)
  • NSE
  • BSE

Overview

  • BSE Code 540222
  • NSE Symbol LAURUSLABS
  • ISIN Demat INE947Q01028
  • Book Value (₹) 84.59
  • Face Value (₹) 2.00
  • Market Cap (₹ Cr.) 44,606.21
  • P/E (TTM) 131.22
  • EPS (TTM) 6.30
  • Div Yield (%) 0.15

Performance

Today’s Low 876.55
Today’s High 922.50

881.45
52W Low 417.70
52W High 922.50

881.45
Open 909.90
Prev. Close 909.85
Volume 49,89,767.00

Corporate Actions

Laurus Labs Limited - Analysts/Institutional Investor Meet/Con. Call Updates
Apr 28, 2025

Laurus Labs Limited has informed the Exchange about Transcript

About Laurus Labs Ltd

Journey of Laurus Labs Limited

Incorporated in 2005, Laurus Labs Limited is involved in the manufacturing of pharmaceutical products.   In 2006, Research & Development (R&D) of the company started, and they signed their first patent application and in the next year, i.e., in 2007, the company established its first manufacturing unit. In the next year they supplied their first product to the USA followed by Europe in 2009. With in 8 years since its inception, in 2013, the company has crossed ₹10 billion in revenues and in the same year it received an approval from WHO for their Unit-I manufacturing site. In the next year, they commenced the construction of manufacturing Unit - II.  In 2016, they launched their IPO and got listed on the exchanges. By 2017, the company had incorporated subsidiaries in the USA and the UK and had 3 manufacturing units in India. In the next year, they expanded their international presence by incorporating a subsidiary in Germany.  As of March 2023, the company had 6 manufacturing units in Visakhapatnam in Andhra Pradesh and 1 in Hyderabad. Laurus Labs Limited have international offices located in Germany, SA, the USA and the UK. They serve their products all over India and in 62 countries worldwide. Laurus Labs Limited has more than 55 state-of-art R&D labs in India, over 90 APIs are manufactured and 322 patents filed. 

Business Segments of Laurus Labs Limited

The primary business segments of the company are as follows:
  • Generic Formulations:Under this segment, the company delivers products or services, such as Anti-retroviral (ARV), Anti-diabetic, Cardiovascular, Proton Pump Inhibitors (PPIs) and Central nervous system (CNS). The company has dedicated formulation research labs, analytical research labs and laboratory-scale clinical supply facilities. They are capable of developing various types of dosage forms.
  • CDMO-Synthesis:In this segment, the company offers Nutraceuticals, dietary supplements and cosmeceutical products. They also offer analytical and research services and commercial scale contract manufacturing.
  • Bio:In this the company offers in-depth fermentation-based product development and manufacturing expertise, as a service to novel protein companies and bio-manufacturers.
  • Generic APIs:Laurus Labs Limited offers generic Active Pharmaceutical Ingredients (APIs) in this segment, such as Anti-retroviral (ARV), Anti-diabetic, Cardiovascular, Proton Pump Inhibitors (PPIs) and Oncology.
As of March 31, 2023, some of the subsidiaries of Laurus Labs Limited are as follows:
  • Laurus Specialty Chemicals Private Limited:This wholly-owned subsidiary of Laurus Labs Limited is involved in the enterprise of Specialty Chemicals.
  • Sriam Labs Private Limited:This wholly-owned subsidiary of the organization is involved in the enterprise of APIs and intermediates.
  • Laurus Holdings Limited, United Kingdom:This wholly-owned subsidiary of Laurus Labs Limited delivers support services in the pharmaceuticals field in the UK.

Key Personalities of Laurus Labs Limited

Dr Satyanarayana Chava, Founder and CEO Dr Satyanarayana Chava is the Executive, Whole Time Director and the Chief Executive Officer of Laurus Labs Limited. He has been the Director of the company since January 21, 2006. Under his supervision, the company has grown immensely and established itself all over the world.
Founded: 2005
Chairman: Ravindranath Kancherla
Address: Plot No 21 Jawaharlal Nehru, Pharma City Parawada, Visakhapatnam, Andhra Pradesh, 531021,
HO Tel: 91-40-3980 4333